Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.

Area of Science:

• Biochemistry
• Neuroimmunology
• Lipid Metabolism

Background:

• Multiple sclerosis (MS) is associated with plasma protein anomalies.
• A previously reported anomaly shares characteristics with phospholipid transfer protein (PLTP).
• PLTP plays a role in lipid homeostasis and high-density lipoprotein remodeling.

Purpose of the Study:

• To identify the plasma protein anomaly in MS patients.
• To investigate the activity of phospholipid transfer protein in MS.
• To explore the potential role of PLTP in MS pathogenesis.

Main Methods:

• Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to detect protein anomalies.
• Western blot analysis using anti-PLTP antibodies for protein identification.
• Plasma phospholipid transfer activity assays in MS patients and controls.
• Gene sequencing of the phospholipid transfer protein.

Main Results:

• The identified anomaly was confirmed as phospholipid transfer protein (PLTP).
• Elevated PLTP activity was observed in fasted plasma samples from MS subjects compared to controls.
• No mutations were found in the PLTP gene sequence, suggesting altered activity is not due to structural changes.
• The increased activity may stem from interactions with other proteins forming active complexes.

Conclusions:

• The study identifies PLTP as the anomaly in MS plasma proteins.
• Elevated PLTP activity in MS could contribute to abnormal lipid metabolism and myelin alterations.
• These lipid changes may influence autoimmune responses and disease course in MS.
• Further research is necessary to fully understand PLTP's role in multiple sclerosis.